Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 4
Results: 9
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 333, doi. 10.1007/s40261-022-01138-6
- By:
- Publication type:
- Article
Comparison of Warfarin Initiation at 3 mg Versus 5 mg for Anticoagulation of Patients with Mechanical Mitral Valve Replacement Surgery: A Prospective Randomized Trial.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 309, doi. 10.1007/s40261-022-01137-7
- By:
- Publication type:
- Article
Tralokinumab in Atopic Dermatitis: A Profile of Its Use.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 365, doi. 10.1007/s40261-022-01135-9
- By:
- Publication type:
- Article
Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [<sup>14</sup>C]‑BI 425809 in Healthy Males.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A Developer's Perspective on Clinical Evidence and Benefits for Rituximab Biosimilar Uptake, with a Focus on CT-P10.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 285, doi. 10.1007/s40261-022-01133-x
- By:
- Publication type:
- Article
Atogepant for Migraine Prevention: A Systematic Review of Efficacy and Safety.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 301, doi. 10.1007/s40261-022-01130-0
- By:
- Publication type:
- Article
Multiple Sclerosis Relapses Following Cessation of Fingolimod.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 355, doi. 10.1007/s40261-022-01129-7
- By:
- Publication type:
- Article
Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 345, doi. 10.1007/s40261-022-01128-8
- By:
- Publication type:
- Article
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 319, doi. 10.1007/s40261-022-01120-2
- By:
- Publication type:
- Article